This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
By Frederick Fromm, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group While caution in some areas of the commodities space may be prudent, there...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....
Repligen (NASDAQ:RGEN) offers a comprehensive suite of products, including filtration, chromatography, process analytics, and proteins, catering to both upstream and downstream processes in the...
Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important...
Investment thesis Synaptics (NASDAQ:SYNA) is experiencing severe headwinds due to the challenging environment with weak end markets’ spending. On the other hand, secular trends...